Literature DB >> 23915977

MiR-125b, miR-100 and miR-99a co-regulate vincristine resistance in childhood acute lymphoblastic leukemia.

F Akbari Moqadam1, E A M Lange-Turenhout, I M Ariës, R Pieters, M L den Boer.   

Abstract

MicroRNA-125b (miR-125b), miR-99a and miR-100 are overexpressed in vincristine-resistant acute lymphoblastic leukemia (ALL). Cellular viability of ETV6-RUNX1-positive Reh cells significantly increased in presence of 9 ng/mL vincristine upon co-expression of miR-125b/miR-99a (91 ± 4%), miR-125b/miR-100 (93 ± 5%) or miR-125b/miR-99a/miR-100 (82 ± 17%) compared with miR-125b-transduced cells (38 ± 13%, P<0.05). Co-expression of these miRNAs resulted in downregulation of DNTT, NUCKS1, MALAT1, SNRPE, PNO1, SET, KIF5B, PRPS2, RPS11, RPL38 and RPL23A (fold-change 1.3-1.9, p<0.05). Similarly, 7 out of these genes are lower expressed in vincristine-resistant ALL cells of children (p<0.05). The concerted function of miR-125b in combination with miR-99a and/or miR-100 illustrates the complexity of vincristine-resistant pediatric ALL.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Leukemia; Vincristine resistance; miR-100; miR-125b; miR-99a; miRNA

Mesh:

Substances:

Year:  2013        PMID: 23915977     DOI: 10.1016/j.leukres.2013.06.027

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  35 in total

Review 1.  Acute lymphoid leukemia etiopathogenesis.

Authors:  Thiago Cezar Fujita; Nathália Sousa-Pereira; Marla Karine Amarante; Maria Angelica Ehara Watanabe
Journal:  Mol Biol Rep       Date:  2021-01-13       Impact factor: 2.316

2.  Overexpression of suppressor of IKBKE 1 is associated with vincristine resistance in colon cancer cells.

Authors:  Chun-Peng Zhao; Zhong-Jie Xu; Qing Guo; Yun-Xiao Li; Xiang-Zheng Gao; Yi-You Peng
Journal:  Biomed Rep       Date:  2016-09-21

Review 3.  Eviction from the sanctuary: Development of targeted therapy against cell adhesion molecules in acute lymphoblastic leukemia.

Authors:  Sonali P Barwe; Anthony Quagliano; Anilkumar Gopalakrishnapillai
Journal:  Semin Oncol       Date:  2017-07-11       Impact factor: 4.929

4.  Altered expression of miR-24, miR-126 and miR-365 does not affect viability of childhood TCF3-rearranged leukemia cells.

Authors:  F Akbari Moqadam; J M Boer; E A M Lange-Turenhout; R Pieters; M L den Boer
Journal:  Leukemia       Date:  2013-10-23       Impact factor: 11.528

5.  Novel insight into MALAT-1 in cancer: Therapeutic targets and clinical applications.

Authors:  Danyang Ren; Huiying Li; Renqiu Li; Jianming Sun; Pin Guo; Huiyun Han; Yuehuang Yang; Jun Li
Journal:  Oncol Lett       Date:  2016-01-22       Impact factor: 2.967

6.  Understanding thrombocytopenia: physiological role of microRNA in survival of neonatal megakaryocytes.

Authors:  Ravinder Kandi; Usha Gutti; Rambabu Undi; Itishri Sahu; Ravi Kumar Gutti
Journal:  J Thromb Thrombolysis       Date:  2015-10       Impact factor: 2.300

7.  Integrative computational in-depth analysis of dysregulated miRNA-mRNA interactions in drug-resistant pediatric acute lymphoblastic leukemia cells: an attempt to obtain new potential gene-miRNA pathways involved in response to treatment.

Authors:  Hamzeh Mesrian Tanha; Marjan Mojtabavi Naeini; Soheila Rahgozar; Alireza Moafi; Mohammad Amin Honardoost
Journal:  Tumour Biol       Date:  2015-12-23

Review 8.  MicroRNAs and Chinese Medicinal Herbs: New Possibilities in Cancer Therapy.

Authors:  Ming Hong; Ning Wang; Hor Yue Tan; Sai-Wah Tsao; Yibin Feng
Journal:  Cancers (Basel)       Date:  2015-08-24       Impact factor: 6.639

9.  Benzene-Induced Aberrant miRNA Expression Profile in Hematopoietic Progenitor Cells in C57BL/6 Mice.

Authors:  Haiyan Wei; Juan Zhang; Kehong Tan; Rongli Sun; Lihong Yin; Yuepu Pu
Journal:  Int J Mol Sci       Date:  2015-11-12       Impact factor: 5.923

10.  Identification of Potential Signatures and Their Functions for Acute Lymphoblastic Leukemia: A Study Based on the Cancer Genome Atlas.

Authors:  Weimin Wang; Chunhui Lyu; Fei Wang; Congcong Wang; Feifei Wu; Xue Li; Silin Gan
Journal:  Front Genet       Date:  2021-07-06       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.